GATA2 promotes cervical cancer progression under the transcriptional activation of TRIP4
Open Access
- 3 April 2025
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 132, 111778
Abstract
No abstract availableKeywords
Funding Information
- Key Research and Development Program of Liaoning Province (2021JH1/10400051)
- National Natural Science Foundation of China (81171486 LZ)
- National Natural Science Foundation of China (81703904 KZ)
This publication has 39 references indexed in Scilit:
- Corrigendum to “TRIP4 transcriptionally activates DDIT4 and subsequent mTOR signaling to promote glioma progression” [Free Radic. Biol. Med. 177 (2021) 31–47]Free Radical Biology and Medicine, 2024
- TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signalingCancer Letters, 2019
- The Human Transcription FactorsCell, 2018
- The Tumor-Promoting Role of TRIP4 in Melanoma Progression and its Involvement in Response to BRAF-Targeted TherapyJournal of Investigative Dermatology, 2018
- Mutations in Subunits of the Activating Signal Cointegrator 1 Complex Are Associated with Prenatal Spinal Muscular Atrophy and Congenital Bone FracturesThe American Journal of Human Genetics, 2016
- Modification of ASC1 by UFM1 Is Crucial for ERα Transactivation and Breast Cancer DevelopmentMolecular Cell, 2014
- The role of the GATA2 transcription factor in normal and malignant hematopoiesisCritical Reviews in Oncology/Hematology, 2012
- Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progressionJournal of Cellular Physiology, 2007
- Developmental control via GATA factor interplay at chromatin domainsJournal of Cellular Physiology, 2005
- A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damageCurrent Biology, 2000